Page last updated: 2024-08-25

tricaprin and Hyperlipoproteinemia Type I

tricaprin has been researched along with Hyperlipoproteinemia Type I in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inadera, H; Kobayashi, J; Mori, S; Ohkubo, Y; Saito, Y; Shirai, K; Yoshida, S	1

Other Studies

1 other study(ies) available for tricaprin and Hyperlipoproteinemia Type I

Article	Year
Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride. Metabolism: clinical and experimental, 1992, Volume: 41, Issue:11 Topics: Adolescent; Carbon Radioisotopes; Chylomicrons; Dietary Fats; Excipients; Fatty Acids; Female; Heparin; Humans; Hydrolysis; Hyperlipoproteinemia Type I; Injections; Lipase; Lipids; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Octoxynol; Polyethylene Glycols; Triglycerides; Triolein	1992

Article

Year

Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.

Metabolism: clinical and experimental, 1992, Volume: 41, Issue:11

Topics: Adolescent; Carbon Radioisotopes; Chylomicrons; Dietary Fats; Excipients; Fatty Acids; Female; Heparin; Humans; Hydrolysis; Hyperlipoproteinemia Type I; Injections; Lipase; Lipids; Lipoprotein Lipase; Lipoproteins, VLDL; Liver; Octoxynol; Polyethylene Glycols; Triglycerides; Triolein

1992